Delivery Order SPE2DR25D1100-SPE2DR26FCV8C
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 units) under a firm fixed-price contract valued at $2,504.60. This award was made on December 5, 2025, with an ultimate completion date of December 8, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order, reflecting the contractor's proven capability...
- The Defense Logistics Agency awarded a delivery order valued at $1,013.49 to AmerisourceBergen Drug Corp for Yuvafem 10 micrograms vaginal inserts (8-count package) on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $1,092.44 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (18-count package) on December 10, 2025, with completion expected by December 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,126.70 to AmerisourceBergen Drug Corp for Yuvafem 10 micrograms vaginal inserts (18 units) on November 26, 2025, with completion scheduled for November 28, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The contractor will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,918.21 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price contract, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, represents a competitively awarded non-set-aside delivery order. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) with a firm fixed price ceiling value of $1,644.36. The order, issued on December 5, 2025, is scheduled for completion by December 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded contract issued as a delivery order under the company's existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.73 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 13, 2025, with completion scheduled for August 14, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, procured through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,170.77 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-pack) with an ultimate completion date of October 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered from the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,425.36 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on December 19, 2025, with completion scheduled for December 22, 2025. This non-competitive delivery order represents a firm fixed price transaction for pharmaceutical supply to support federal medical procurement needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $6,425.86 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price contract reflects a routine pharmaceutical supply procurement from the company's existing indefinite delivery contract with DLA. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCV8CDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 micrograms vaginal inserts (18 units) under a firm fixed-price contract valued at $2,103.45. The award was issued on December 19, 2025, with an ultimate completion date of December 22, 2025. This non-set-aside delivery order is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under a larger vehicle. This delivery order is issued under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded contracts across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/18/25 |